Pfizer-BioNTech’s decision to be able to move its doses of COVID-19 vaccines from one place to another will have a beneficial effect for the Gaspé.
Struggling with a population spread over a vast territory, public health had to use complex logistics for the use of doses when they arrived in Gaspé territory.
The vaccine, which must be kept around -80 Celsius, was shipped in a single batch of 975 and was to remain at the receiving site.
The Director of Public Health, Dr Yv Bonnier-Viger, explains that being able to separate and move the doses will be an important advantage in vaccinating the population:
The doctor gives the example of a small residence for seniors of about thirty people who could not have access to the vaccine on site:
This Pfizer decision will also allow vaccination to go a little faster. This will also allow the vaccines to be administered to the highest priority people instead of using them for other people at lower risk since the doses could not be moved.
2.9% of the population has been vaccinated so far in the Gaspé.